The fate of FDA postapproval studies

Steven Woloshin; Lisa M. Schwartz; Brian White; Thomas J. Moore

doi:10.1056/NEJMp1705800

The fate of FDA postapproval studies

Steven Woloshin, Lisa M. Schwartz, Brian White, Thomas J. Moore

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	1114-1117
Number of pages	4
Journal	New England Journal of Medicine
Volume	377
Issue number	12
DOIs	https://doi.org/10.1056/NEJMp1705800
State	Published - Sep 21 2017
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMp1705800

Cite this

@article{c283910ef1b34b648f9a35fecf1105ed,

title = "The fate of FDA postapproval studies",

author = "Steven Woloshin and Schwartz, {Lisa M.} and Brian White and Moore, {Thomas J.}",

year = "2017",

month = sep,

day = "21",

doi = "10.1056/NEJMp1705800",

language = "English (US)",

volume = "377",

pages = "1114--1117",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "12",

}

TY - JOUR

T1 - The fate of FDA postapproval studies

AU - Woloshin, Steven

AU - Schwartz, Lisa M.

AU - White, Brian

AU - Moore, Thomas J.

PY - 2017/9/21

Y1 - 2017/9/21

UR - http://www.scopus.com/inward/record.url?scp=85029558734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029558734&partnerID=8YFLogxK

U2 - 10.1056/NEJMp1705800

DO - 10.1056/NEJMp1705800

M3 - Short survey

C2 - 28930510

AN - SCOPUS:85029558734

VL - 377

SP - 1114

EP - 1117

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 12

ER -

The fate of FDA postapproval studies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this